Cargando…
Does Transient Receptor Potential Vanilloid Type 1 Alleviate or Aggravate Pathological Myocardial Hypertrophy?
Transient receptor potential vanilloid type 1 (TRPV1) is a non-selective cation channel, which is involved in the endogenous stress adaptation mechanism for protection of the heart as well as the occurrence and development of some heart diseases. Although the effect of activation of the TRPV1 channe...
Autores principales: | Yan, Qiqi, Tang, Jun, Zhang, Xin, Wu, Liuyang, Xu, Yunyi, Wang, Lihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143375/ https://www.ncbi.nlm.nih.gov/pubmed/34040539 http://dx.doi.org/10.3389/fphar.2021.681286 |
Ejemplares similares
-
Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats
por: Zhang, Qianhui, et al.
Publicado: (2018) -
Transient receptor potential vanilloid subtype 1: A potential therapeutic target for fibrotic diseases
por: Peng, Guangxin, et al.
Publicado: (2022) -
Blockage of transient receptor potential vanilloid 4 alleviates myocardial ischemia/reperfusion injury in mice
por: Dong, Qian, et al.
Publicado: (2017) -
Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy
por: Zhu, Fuyu, et al.
Publicado: (2022) -
Transient Receptor Potential Vanilloid 2 Regulates Myocardial Response to Exercise
por: Naticchioni, Mindi, et al.
Publicado: (2015)